Home Evolva

Evolva

acquired
Post-IPO Round
Biological Component Developer
Basic
Enterprise Profile

Basic Information

Evolva was founded in 2004 around a unique proprietary technology platform that utilizes synthetic biology to create innovative small molecule drugs and other compounds. Specifically, their platform allows for the creation of cosmetics that mimic the themes found in natural products but without the drawbacks of these methods.
Evolva A/S
Geneva,CantonofGeneva,Switzerland
51~100 people
January 01, 2004
info@evolva.com

Enterprise Profile

Industrial Sector
Biomanufacturing Compound Discovery New Drug Development
Technology
Microbial/Viral Technology Synthetic Biology
Concept
Disease Treatment
Application Scenarios
Chemical Drug Innovative Drugs